Top

Press Releases

Filter by

Clear filters
19 March 2024

Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate

Prof Lee Fairlie, Wits RHI’s Director of Maternal and Child Health is the Co-National Principal Investigator with Prof Willem Hanekom (AHRI) for the TB trial in South Africa. Read the official press release by the Bill & Melinda Gates Research Institute.

View more

19 March 2024

Late-stage trial for tuberculosis vaccine candidate underway in South Africa

Prof Lee Fairlie, Wits RHI’s Director of Maternal and Child Health is the Co-National Principal Investigator with Prof Willem Hanekom (AHRI) for the TB trial in South Africa. Read the official press release by the Wellcome Trust.

View more

18 March 2024

Prototypes of a novel vaginal ring design being put to the test in a study that will inform final design of a dual-purpose ring for prevention of both HIV and unplanned pregnancy

Researchers are currently testing prototypes of a new vaginal ring design in a study that aims to finalize a dual-purpose ring for preventing both HIV and unplanned pregnancy. This study is part of MATRIX, a USAID project focused on advancing research and development of innovative HIV prevention products for women.…

View more

2 November 2023

Researchers launch first study of a vaginal film that dissolves in 30 days to assess its acceptability as a potential HIV prevention method for women

Exciting developments: MATRIX has launched the 1st study of a vaginal film that dissolves in 30 days to assess its acceptability as a potential women’s #HIVprevention method – two prototype films are being evaluated in the study at five sites in the US and Africa. Read the official press release…

View more

2 November 2023

New Gonorrhoea Treatment Shows Positive Results in Trial Sponsored by Non-Profit Partnership

Positive results announced in largest pivotal phase 3 trial of a first-in-class oral antibiotic to treat uncomplicated gonorrhoea. Our team at Wits RHI was proud to contribute to the success of this study in South Africa. Well done to the team !!! Prof Sinead Delany-Moretlwe, principal investigator for the trial…

View more

2 November 2023

Researchers Launch First Study Of A Vaginal Film That Dissolves In 30 Days

Exciting developments: MATRIX has launched the 1st study of a vaginal film that dissolves in 30 days to assess its acceptability as a potential women’s #HIVprevention method – two prototype films are being evaluated in the study at five sites in the US and Africa. Read the official press release…

View more

24 August 2023

European Commission Approves Pfizer’s ABRYSVO to Help Protect Infants through Maternal Immunization and Older Adults from RSV

Pfizer Matisse Study The Maternal and Child Health team was elated to hear the news that the study product ABRYSVO- developed by Pfizer (bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) vaccine) has been approved by the FDA as well as the EU, as the first maternal vaccine and an…

View more

2 June 2023

Wellcome’s Heat Adaptation Funding Announcement

JOINT MEDIA RELEASE 02 June 2023 Climate change - heat in particular – is threatening human health around the world. Affordable, effective, interventions that can protect health are critical, but global evidence is lacking on what works best. To advance global solutions, Wellcome is today announcing £17.5m to support research…

View more

29 March 2023

Congratulations Class Of 2023!

The conferment of this honorary degree showcases Helen’s extensive national, continental and global contribution in the field of medicines control. This includes her involvement in the national and global responses to the COVID-19 pandemic, including the development of COVID-19 vaccines was acknowledged as was an outstanding and selfless service to…

View more

28 March 2023

Rhodes University honours global health researcher Professor Helen Rees

JOINT MEDIA RELEASE 28 March 2023 At its graduation ceremony on Friday, 31 March 2023, Rhodes University will confer a degree of Doctor of Laws (LLD) (honoris causa) on Executive Director at Wits Reproductive Health and HIV Institute Professor Helen Rees. Prof Rees is internationally recognised as an award-winning global…

View more

5 September 2022

Heat Indicators for Global Health (HIGH Horizons)

HIGH Horizons JOINT MEDIA RELEASE Aims and objectives The HIGH Horizons project aims to identify cost-effective, integrated adaptation-mitigation interventions to alleviate heat impacts on health workers, and to reduce carbon emissions associated with health care. The project also aims to implement a system for monitoring the global-, national- and district-level…

View more

18 March 2022

Unitaid to introduce new long-lasting injection to prevent HIV in Brazil and South Africa

JOINT MEDIA RELEASE Geneva - 18 March 2022 People at risk of HIV in Brazil and South Africa will be among the first to benefit from a highly effective, long-acting injectable HIV preventive treatment through two large-scale operational projects funded by global health agency Unitaid. Long-acting cabotegravir is a new…

View more

1 March 2022

French National Order of Merit Awarded to Professor Helen Rees

Professor Helen Rees; French National Order of Merit Award; Wits RHI JOINT MEDIA RELEASE Johannesburg, South Africa Wits RHI Executive Director, Professor Helen Rees, has been awarded the prestigious L’ordre national du Mérite (National Order of Merit) by the President of the French Republic Emmanuel Macron, in recognition of her…

View more

10 November 2020

HIV drug study shows long-acting injection is more effective than current daily HIV pill

JOINT MEDIA RELEASE 10 November 2020 Early unblinding of the pre-exposure prophylaxis regimen of long-acting cabotegravir (CAB LA) is a milestone for prevention of HIV among women in sub Saharan Africa For more details view the study press releases Researchers from the HIV Prevention Trials Network (HPTN) announced today that…

View more

13 June 2019

ECHO Study Results Release

JOINT MEDIA RELEASE Durban, South Africa - 13 June 2019 ECHO finds no substantial difference in HIV risk among DMPA-IM,copper IUD, and LNG implant users. DURBAN (South Africa) 13 June 2019 – A pivotal clinical trial to address a long-standing question about the relationship between hormonal contraceptive use and the…

View more

8 April 2019

Wits RHI’s New Programme to Prevent School Based HIV and GBV

JOINT MEDIA RELEASE 08 April 2019 Wits RHI is proud to announce the launch of a USAID-funded five year (2018 - 2023) School Based HIV and Gender Based Violence (GBV) Prevention Programme.Wits RHI will work directly with the Department of Basic Education (DBE) to reduce the incidence of HIV, tuberculosis…

View more

5 February 2019

Wits RHI to Launch the First HPV Vaccine Impact Evaluation Project in Africa

Bill and Melinda Gates Foundation, HPV, vaccination, campaign, adolescent girls, Sinead Delany-Moretlwe, cervical cancer JOINT MEDIA RELEASE Johannesburg - 05 February 2019 Wits RHI is the successful recipient of two awards from the Bill and Melinda Gates Foundation and the National Health and Medical Research Council of Australia for over…

View more

16 October 2018

First Dedicated Clinics to Open for Transgender Care under Key Populations Award

Sex worker, transgender, key populations, HIV, SWEAT, ART, USAID, Key populations programme, PrEP JOINT MEDIA RELEASE Johannesburg - 16 October 2018 The Wits RHI Key Populations Programme is the successful recipient of a 5-year USAID Award for advancing the South African HIV Response for Key Populations, Sex Workers, and Transgender…

View more

12 February 2018

Appointment of the South African Health Products Regulatory Authority (SAHPRA) Board

monitoring, evaluation, regulation, radiation control, medicines, SAHPRA, JOINT MEDIA RELEASE Johannesburg - 12 February 2018 Appointment of the South African Health Products Regulatory Authority (SAHPRA) Board The Minister of Health, Dr Aaron Motsoaledi, has appointed members of the South African Health Products Regulatory Authority (SAHPRA) Board. SAHPRA replaces the Medicines…

View more

5 December 2017

South Africa to launch HIV prevention project

HIV, prevention, PrEP, adolescent, antiretroviral, Saiqa Mullick, Helen Rees, Department of Health JOINT MEDIA RELEASE Johannesburg - 05 December 2017 South Africa to launch HIV prevention project A highly effective oral medication to prevent HIV will be provided to young women in South Africa at high risk of getting the…

View more

1 November 2017

Wits and Vaccines: The Impact and Potential of Vaccines for Africa

Johannesburg - 01 November 2017 Wits and Vaccines: The Impact and Potential of Vaccines for Africa The development of vaccines has greatly impacted on the reduction of mortality rates across the globe, while the importance of developing more vaccines to curb the threat of emerging diseases cannot be stressed enough.…

View more

16 January 2017

ADVANCE Study – Study launched to test new and safer HIV drugs

Antiretroviral, HIV, treament, drugs, ADVANCE, ART, USAID JOINT MEDIA RELEASE Johannesburg - 16 January 2017 “ADVANCE Study” – Study launched to test new and safer HIV drugs Wits Reproductive Health and HIV Institute (Wits RHI) and their partners are excited to announce the launch today of a study, ADVANCE, to…

View more

7 December 2016

Wits RHI Receives Grant to Speed up Access to Critical HIV Drugs

TB, HIV, grant, ADVANCE, ART,UNITAID, TAC, SAHCS JOINT MEDIA RELEASE Johannesburg - 07 December 2016 Wits RHI Receives Grant to Speed up Access to Critical HIV Drugs The Wits Reproductive Health and HIV Institute (Wits RHI) today announced a new partnership with UNITAID. The partnership will support efforts to optimise…

View more

31 August 2016

Mobile Alliance for Maternal Action (MAMA)

Hillbrow,Johannesburg - 31 August 2016 Imagine getting accurate, reliable information on everything from breastfeeding to eating well in pregnancy and when to visit the clinic, directly on your cell phone? This is the power of health that the Mobile Alliance for Maternal Action (MAMA) is putting in the hands of…

View more

10 December 2015

USAID selects innovative South African organizations to address HIV/AIDS globally

USAID, Right to Care, Wits Reproductive Health Institute JOINT MEDIA RELEASE Washington, Johannesburg - 10 December 2015 USAID has recognised the expertise of two South African-led consortia to address the global challenge of treating those infected by HIV/AIDS. These consortia are led by Right to Care and the Wits Reproductive…

View more

1 December 2015

Harry Oppenheimer Fellowship Award

Top scientist at the University of the Witwatersrand receives the Oppenheimer Fellowship JOINT MEDIA RELEASE Johannesburg - 01 December 2015 The Board of the Oppenheimer Memorial Trust is pleased to announce the recipient of the prestigious Harry Oppenheimer Fellowship Award for 2014: Professor Helen Rees of the University of the…

View more

1 November 2015

Professor Helen Rees leads African Scientists in signing Global Declaration to End Polio

Experts from 80 countries cite time-limited opportunity, endorse comprehensive new eradication strategy. JOINT MEDIA RELEASE Johannesburg - 01 November 2015 Professor Helen Rees, Executive Director of WRHI, joined hundreds of scientists, doctors and other experts from around the world to launch the Scientific Declaration on Polio Eradication, declaring that an…

View more

Stay up to date

Get updates on news, resources, events and happenings from Wits RHI.